汉字News

← 汉字News
Chinese News for Learners
technology
kē jì
科技
·HSK 6

Novo Nordisk
Nuòhé Nuòdé
诺和诺德
and / with
OpenAI (AI company)
OpenAI
OpenAI
to reach / to conclude
dáchéng
达成
strategic
zhànlüè
战略
partnership / cooperation
hézuò
合作
in order to
artificial intelligence
rén gōng zhìnéng
人工智能
to accelerate
jiāsù
加速
drug / medicine
yàowù
药物
research and development
yán fā
研发

Denmark
Dānmài
丹麦
pharmaceutical
zhìyào
制药
giant / major player
jùtóu
巨头
Novo Nordisk
Nuòhé Nuòdé
诺和诺德
with
OpenAI
OpenAI
OpenAI
on (date marker)
April 14th
4 yuè 14 rì
4月14日
to announce
xuānbù
宣布
to reach
dáchéng
达成
strategic
zhànlüè
战略
partnership
hézuò
合作
to cover / to encompass
hángài
涵盖
drug / medicine
yàowù
药物
research and development
yán fā
研发
manufacturing / production
shēngchǎn
生产
and / as well as
commercial / business
shāngyè
商业
operations
yùnyíng
运营
entire chain / end-to-end
quán liàntiáo
全链条
the said
gāi
partnership
hézuò
合作
aimed at / with the goal of
zhǐzài
旨在
by means of / with the help of
jièzhù
借助
artificial intelligence
rén gōng zhìnéng
人工智能
to shorten / to reduce
suōduǎn
缩短
drug
yàowù
药物
from
cóng
research
yánjiū
研究
to
dào
clinical
línchuáng
临床
application / use
yìngyòng
应用
(possessive / modifier particle)
de
cycle / timeline
zhōuqī
周期

May 7, 2026 at 5:00 AM

Denmark
Dānmài
丹麦
pharmaceutical
zhìyào
制药
giant / major player
jùtóu
巨头
Novo Nordisk
Nuòhé Nuòdé
诺和诺德
on (date marker)
April 14th
4 yuè 14 rì
4月14日
to announce
xuānbù
宣布
with
OpenAI
OpenAI
OpenAI
to reach / to conclude
dáchéng
达成
comprehensive / full
quánmiàn
全面
strategic
zhànlüè
战略
partnership agreement
hézuò xiéyì
合作协议
according to / based on
gēnjù
根据
agreement
xiéyì
协议
OpenAI
OpenAI
OpenAI
(possessive / modifier particle)
de
technology
jìshù
技术
will
jiāng
(passive voice marker)
bèi
comprehensively
quánmiàn
全面
to integrate / to incorporate
zhěnghé
整合
into
zhì
Novo Nordisk
Nuòhé Nuòdé
诺和诺德
(possessive / modifier particle)
de
drug
yàowù
药物
research and development
yán fā
研发
manufacturing
zhìzào
制造
supply chain
gōngyìng liàn
供应链
and / as well as
commercial
shāngyè
商业
operations
yùnyíng
运营
each / every
link / stage
huánjié
环节
partnership / collaboration
hézuò
合作
(possessive / modifier particle)
de
core / central focus
héxīn
核心
goal / objective
mùbiāo
目标
lies in / is centered on
zàiyú
在于
by means of
jièzhù
借助
artificial intelligence
rén gōng zhìnéng
人工智能
to analyze
fēnxī
分析
complex
fùzá
复杂
datasets
shùjù jí
数据集
to identify
shíbié
识别
new / novel
xīnxíng
新型
candidate
hòuxuǎn
候选
drugs / compounds
yàowù
药物
thereby / so as to
cóng'ér
从而
significantly
dàfú
大幅
to shorten / to reduce
suōduǎn
缩短
R&D
yán fā
研发
cycle / timeline
zhōuqī
周期
this time / on this occasion
cǐ cì
此次
collaboration
hézuò
合作
also / furthermore
to cover / to encompass
hángài
涵盖
employees / workforce
yuángōng
员工
artificial intelligence
rén gōng zhìnéng
人工智能
literacy / capability
sùyǎng
素养
training
péixùn
培训
planned / scheduled
jìhuà
计划
by
end of 2026
2026 nián dǐ
2026年底
before
qián
to complete
wánchéng
完成
full / comprehensive
quánmiàn
全面
deployment / rollout
bùshǔ
部署
in terms of background / contextually
bèijǐng shàng
背景上
Novo Nordisk
Nuòhé Nuòdé
诺和诺德
is currently facing
zhèng miànlín
正面临
from
láizì
来自
US
Měiguó
美国
competitor / rival
jìngzhēng duìshǒu
竞争对手
Eli Lilly
Lǐlái
礼来
(possessive / modifier particle)
de
intense / fierce
jīliè
激烈
competition
jìngzhēng
竞争
especially / particularly
yóuqí
尤其
manifested in / particularly in
tǐxiàn zài
体现在
body weight
tǐzhòng
体重
management
guǎnlǐ
管理
drugs
yàowù
药物
field / sector
lǐngyù
领域
the industry
yèjiè
业界
analysts
fēnxī rénshì
分析人士
to believe / to argue
rènwéi
认为
this
cǐ cì
此次
collaboration
hézuò
合作
could help
yǒu zhù yú
有助于
Novo Nordisk
Nuòhé Nuòdé
诺和诺德
in
zài
next-generation
xià yī dài
下一代
weight-loss
jiǎnféi
减肥
drugs
yàowù
药物
R&D
yán fā
研发
in terms of / aspect
fāngmiàn
方面
to regain / to reclaim
chóngshí
重拾
competitive
jìngzhēng
竞争
advantage
yōushì
优势

New Words

zhìyào
制药
pharmaceutical
jùtóu
巨头
giant / major player
dáchéng
达成
to reach / to conclude
zhànlüè hézuò
战略合作
strategic partnership
zhěnghé
整合
to integrate
yán fā
研发
research and development
zhōuqī
周期
cycle / timeline
sùyǎng
素养
literacy / capability
jìngzhēng duìshǒu
竞争对手
competitor / rival
yōushì
优势
advantage

News in English

Science & Technology

Novo Nordisk Partners With OpenAI to Accelerate Drug Discovery Using AI

Danish pharmaceutical giant Novo Nordisk and OpenAI announced a strategic partnership on April 14, covering drug discovery, manufacturing, and commercial operations end-to-end. The collaboration aims to use AI to shorten the timeline from research to clinical use.

On April 14th, Danish pharmaceutical giant Novo Nordisk announced a comprehensive strategic partnership agreement with OpenAI. According to the agreement, OpenAI's technology will be comprehensively integrated into Novo Nordisk's drug research and development, manufacturing, supply chain, and commercial operations at every stage.

The core objective of this collaboration is to use artificial intelligence to analyze complex datasets, identify new candidate drugs, and thereby significantly shorten the R&D cycle. The collaboration also includes AI literacy training for employees, with plans for full deployment by the end of 2026.

In context, Novo Nordisk is facing intense competition from US competitor Eli Lilly, particularly in the weight-loss drug field. Industry analysts believe this collaboration could help Novo Nordisk regain competitive advantage in next-generation weight-loss drug development.

More in Science & Technology

Apple (company)
Píngguǒ
苹果
with / and
Intel (chip company)
Yīngtèěr
英特尔
to reach / to conclude (a deal)
dáchéng
达成
chip
xīnpiàn
芯片
contract manufacturing
dàigōng
代工
agreement
xiéyì
协议

Apple and Intel Reach Chip Manufacturing Agreement in the United States

OpenAI (AI company)
OpenAI
OpenAI
to consider
kǎolǜ
考虑
will / to
jiāng
to go public / IPO
shàngshì
上市
to postpone / to delay
tuīchí
推迟
until / to
zhì
the year 2027
2027 nián
2027年

OpenAI Considers Delaying IPO Until 2027 After SpaceX Stock Volatility

DeepSeek (AI company name)
Shēndù Qiúsuǒ
深度求索
to complete / to finish
wánchéng
完成
first round (of funding)
shǒu lún
首轮
external / outside
wàibù
外部
to raise funds / financing
róngzī
融资
valuation
gūzhí
估值
to exceed / to surpass
chāoguò
超过
$50 billion
500 yì měiyuán
500亿美元

DeepSeek Completes First External Funding Round at Over $50 Billion Valuation

Alibaba
Ālǐbābā
阿里巴巴
Qwen
tōngyì
通义
Qwen
qiānwèn
千问
App
yìngyòng
应用
opens
kāifàng
开放
third-party
dì sān fāng
第三方
agent
zhìnéng tǐ
智能体
integration
jiērù
接入

Alibaba Qwen App Opens Platform to Third-Party AI Agents